MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway

Abstract

BackgroundRheumatoid arthritis (RA) is a chronic systemic auto- immune disease characterized by joint synovitis. Recent evidence suggests that rheumatoid arthritis synovial fibroblasts (RASFs) promote joint destruction. In this study, we investigated the role of microRNA-26b (miR-26b) in cell proliferation and inflammatory cytokine secretion using patient-derived Rheumatoid arthritis fibroblast-like synoviocyte (RAFLS) to understand pathways influencing rheumatoid arthritis.MethodsRAFLS were cultured in vitro and transfected with miR-26b mimics (experimental group) and negative sequence (control group). The protein levels of Wnt4, Wnt5ɑ, GSK-3β, CyclinD1, Ser9-GSK-3β and β-catenin were detected by western blot analysis. Tumor Necrosis Factor-ɑ (TNF-ɑ), IL- 1β, and IL-6 levels were quantified by Enzyme-linked Immunosorbent Assay (ELISA). RAFLS proliferation and apoptosis were measured by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide (MTT) assay and flow cytometry, respectively.ResultsGSK-3β and CyclinD1 expression levels were lower in miR-26b mimic group compared to Mock group and negative control (NC) group. Conversely, GSK-3β and CyclinD1 expression levels were markedly higher in the miR-26b inhibitor group compared to Mock and NC group (P < 0.05). Transfection of miR-26b mimics significantly increased the, levels of Ser9-GSK-3β and β-catenin in comparison to Mock and NC groups, while transfection of miR-26b inhibitors showed the opposite effect. In miR-26b mimic group, TNF-α, IL- 1β and IL-6 levels were lower than the Mock and NC groups, while in miR-26b inhibitor group, these cytokine levels were higher than the Mock and NC groups (P < 0.05). Transfection of miR-26b mimics significantly reduced the cell proliferation of RAFLS, compared to the Mock and NC groups, and miR-26b inhibitors increased the proliferative capacity of RAFLS compared to Mock and NC groups (P < 0.05). The miR-26b mimic group exhibited higher RAFLS apoptosis rate compared to Mock and NC group and miR-26b inhibitor group showed significantly lower RAFLS apoptosis rate compared to Mock and NC groups (P < 0.05).ConclusionsMiR-26b regulates β-catenin and CyclinD1 levels by inhibiting GSK-3β expression, which in-turn alters the Wnt/GSK-3β/β-catenin pathway to lower RAFLS proliferation and elevate cell apoptosis and the secretion of TNF-α,IL-1β and IL-6 cytokines. Therefore, our results show that miR-26B plays a central role in inhibiting the inflammation associated with rheumatoid arthritis.Virtual SlidesThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9063056861547150

Epigenetics in rheumatoid arthritis; fibroblast‐like synoviocytes as an emerging paradigm in the pathogenesis of the disease

“…By inhibiting the GSK‐3β expression, miR‐26b was identified as an activator of Wnt signaling through inducing β‐catenin and cyclin D1. This activation resulted in reduced proliferation and increased apoptosis of FLSs as well as the synthesis of inflammatory mediators from FLSs . Aberrant expression of miR‐221, miR‐222 and miR‐323‐3p was seen in RA FLSs, and miR‐323‐3p regulated the Wnt signaling positively in RA FLSs through suppressing beta‐transducin repeat containing E3 ubiquitin protein ligase, which is involved in repressing the accumulation of β‐catenin …”

Impact of miR‐26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non‐canonical Wnt signalling

“…These results suggest that miR‐26b is likely to play an important role in development and maintaining cardiac function. Previous studies have also shown that miR‐26b could regulate β‐catenin levels by inhibiting Gsk3β, then affected the Wnt/Gsk3β/β‐catenin axis to elevate rheumatoid arthritis synovial fibroblasts (RAFLS) apoptosis and reduce the secretion of TNF‐α, IL‐1β and IL‐6 to inhibit the inflammation . Although miR‐26b plays a potential role in the regulation of the Wnt signalling pathway by targeting Gsk3β in RAFLS, whether it can mediate Wnt signalling to regulate the cardiomyocyte differentiation remains unclear.…”

MiR-338-5p Promotes Inflammatory Response of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via TargetingSPRY1

“…Rheumatoid arthritis (RA) has been affecting 1% of the world's population [Schellekens et al, ]. It is known as a common autoimmune disease, with main characteristics of joint swelling, cartilage destruction, joint stiffness, and deformity [Sun et al, ; van der Geest et al, ; Prete et al, ; Smigielska‐Czepiel et al, ]. Current therapeutic methods of RA are prone to invasive antirheumatic therapy in the early phase of the pathogenesis.…”